Author:
Ji Kun,Shi Yang,Liang Zhiying,Zhang Cong,Jing Li,Xu Tiantian,Cao Shoujin,Zhou Guanhui,Cao Yunbo,Niu Jiahua,Zhu Jinghua,Ai Jing,Li Zhen,Chen Feng
Reference37 articles.
1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: a meta-analysis;Arvind;Metabolism,2021
3. Curative-intent therapies in localized hepatocellular carcinoma;O'Leary;Curr Treat Options Oncol,2020
4. Electronic address eee, European Association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver;J Hepatol,2018
5. Application of radiomics in the efficacy evaluation of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis;Wang;Acad Radiol,2024